Incyte looks to widen Monjuvi’s net with label expansion bid after phase 3 lymphoma win zbecker Fri, 08/16/2024 – 11:06 More: Incyte looks to widen Monjuvi's net with label expansion bid after phase 3 lymphoma win Source: fierce
read moreFDA signs off on AZ’s Imfinzi in NSCLC despite concerns about trial design kdunleavy Fri, 08/16/2024 – 10:53 More: FDA signs off on AZ's Imfinzi in NSCLC despite concerns about trial design Source: fierce
read moreNovo Nordisk plans new $220M raw ingredients plant in Denmark fkansteiner Fri, 08/16/2024 – 10:22 More: Novo Nordisk plans new 0M raw ingredients plant in Denmark Source: fierce
read moreGSK notches another Zantac win as Florida court tosses expert testimony linking heartburn drug to cancer fkansteiner Fri, 08/16/2024 – 09:48 More: GSK notches another Zantac win as Florida court tosses expert testimony linking heartburn drug to cancer Source: fierce
read moreFierce Pharma Asia—Merck-Curon bispecific deal; Legend’s path forward; Missing adverse events in Amgen FDA filing aliu Fri, 08/16/2024 – 08:07 More: Fierce Pharma Asia—Merck-Curon bispecific deal; Legend's path forward; Missing adverse events in Amgen FDA filing Source: fierce
read more
The study yielded over one million dose-responsive curves for existing cancer drugs More: Researchers map interactions of 144 active substances to identify drug benefits Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals